Benign Prostatic Hyperplasia Surgical Devices Market Insights
The non-cancerous enlargement of the prostate is known as benign prostate hyperplasia (BPH). The treatment option is determined by a number of factors, including the patient’s age, the size of the prostate gland, and the severity of the disease. BPH is a common problem affecting over 20% of men in the U.S. representing around 15 million men, according to an article published in Urologic Clinic of North America in 2016. Medication, surgery such as open prostatectomy and transurethral resection of the prostate (TURP), and minimally invasive therapies such as transurethral needle ablation (TUNA), laser therapy, radiofrequency ablation, implants, and others are among some of the treatment options.
Get Your FREE Sample Copy of the Benign Prostatic Hyperplasia Surgical Devices Market Report 2021
Growing demand for minimally invasive therapies is projected to propel the global benign prostatic hyperplasia surgical devices market.
Minimally invasive surgeries have gained popularity in recent years due to benefits such as reduced postoperative pain, shorter recovery times, shorter hospital stays, fewer surgical scars, laparoscopic incisions being safer than open incisions, equal to or better safety and efficacy in abdominal and general surgeries when compared to open surgeries, and these surfactants. Furthermore, rather than being dependent on medications for a long time, these therapies provide a one-time permanent solution. More than 60% and 20% of patients with benign prostatic hyperplasia are currently taking medication and being monitored. These groups are being targeted by minimally invasive therapies, that have had some success in attracting all those customers.
For instance, implant, which was introduced to the US market in 2013-14 by NeoTract, Inc. (now acquired by Teleflex Inc), saw exponential revenue growth in the last two years, 2015 and 2016. The revenue generated in the first two quarters of 2017 alone surpassed that of the preceding year (i.e. 2016), and the remaining two quarters of the year are expected to perform similarly. Implant revenue may account for nearly 40% of the total benign prostatic hyperplasia surgical devices market by 2025, which is significant given the recent introduction of products on the market. There are other innovative therapies, such as Merit Medical Systems, Inc.’s prostate artery embolization and Procept BioRobotics’ aquablation device, which have shown promising therapeutic results in clinical tests. These products with better efficacy are expected to increase adoption rates significantly, boosting market growth.
In 2016, the global benign prostatic hyperplasia surgical devices market was estimated to be at US$ 375 million and is projected to witness a strong CAGR of 7.5 % over the forecast period (2017 – 2025).
Buy Now This Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/1199
Reasons to Purchase this Report
• Current and future of global Benign Prostatic Hyperplasia Surgical Devices market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
“Limited Time Offer”
Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/1199
Growing geriatric population is expected to fuel the expansion of the global benign prostatic hyperplasia surgical equipment market.
Benign prostatic hyperplasia (BPH) is the most familiar prostate problem among men aged 50 and above and its presence rises with age. According to the U.S. Census Bureau, an estimated 617.1 million people aged 65 and above lived in the world in 2015, out of 7.3 billion people, and the number of geriatric populations is likely to increase to over 60% by 2030, indicating the potential population base associated with lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia. According to the Population Reference Bureau, the number of Americans aged 65 and up is expected to more than double from 2014 to 98 million by 2060, accounting for roughly one-fourth of the total population. Companies, particularly start-ups working on novel therapies such as ProVerum Limited, ProArc Medical, and Zenflow, and others, will benefit greatly from the growing ageing population.
Olympus Corporation, Boston Scientific Corporation, Medifocus Inc., KARL STORZ SE & Co. KG, NxThera, Inc., ProArc Medical, Lisa Laser Products OHG, and Richard Wolf Gmbh are some of the major players in the benign prostatic hyperplasia surgical devices market.
View Press Release For More Information
Table of Contents
- Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Mergers & Acquisitions and Investments
- Start-Up Presence
- Epidemiology
- Impact Analysis
- Regulatory Scenario
- Pipeline Analysis
- Technology Evolution
- Benign Prostatic Hyperplasia Management Framework
- Market Dynamics
- Global Benign Prostatic Hyperplasia Surgical Devices Market, By Product Type, 2015–2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Resectoscopes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
- Radiofrequency Ablation Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
- Urology Lasers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
- Prostatic Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
- Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
- Introduction
- Global Benign Prostatic Hyperplasia Surgical Devices Market, By End User, 2015–2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
- Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
- Introduction
- Global Benign Prostatic Hyperplasia Surgical Devices Market, By Region, 2015–2025 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2025
- North America
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of APAC
- Latin America
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Other Exclusive Reports:
Blood Processing Devices and Consumables Market
Pre-owned Medical Devices Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837